Articles From: AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting to Ambac to Release Third Quarter 2014 Earnings on November 10, 2014


Data from Sublingual Sufentanil Development Program Highlights Analgesic Response Compared to IV Morphine in Young vs Elderly Adult Patients REDWOOD CITY, Calif.
Sign-up for AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting investment picks
Adobe (Nasdaq:ADBE) today announced a partnership with Workday (NYSE:WDAY) to integrate Adobe EchoSign e-signature capabilities into Workday Human Capital Management (HCM), an end-to-end cloud system that enables organizations to make faster decisions and gain operational visibility.
Sign-up for Adobe Partners with Workday to Modernize HR Processes with E-signatures investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154137&ProfileId=051205&sourceType=1 DENVER, CO --
Sign-up for Advanced Cannabis Solutions Completes Acquisition of Retail Bank and Office Building Moving Aggressively to Create "The Greenhouse" Office Space investment picks
2014/10/27
http://media.marketwire.com/attachments/201410/TN-285678_T6391complete.jpg Advantest's new T6391 provides a comprehensive, high-speed test solution for all types of display driver ICs including those with high pin counts, fast interfaces and analog circuits.
Sign-up for Advantest Introduces Leading-Edge Tester for Display Driver Semiconductors Used in High-Resolution LCD Panels investment picks
2014/10/27
Transition from AT&T to Frontier Now Offers Locally Zoned Advertising Capabilities for Local, Regional & National Advertisers LEXINGTON, Ky.
Sign-up for Advertising Sales of Former AT&T U-verse® Subscribers in Connecticut and NY DMA's Move to Viamedia as Frontier Communications Assumes Control investment picks
Teen Retailer Partners with Social Media Influencers Nash Grier, Hayes Grier, Cameron Dallas & Carter Reynolds to Design First Fashion Line NEW YORK , Oct.
Sign-up for Aeropostale Launches Exclusive UNITED XXVI Collection With Social Media Stars investment picks
Agenus Inc. (NASDAQ: AGEN) will report its third quarter 2014 financial results before the market opens on Friday, October 31, 2014.
Sign-up for Agenus to Report Third Quarter 2014 Financial Results on October 31, 2014; Conference Call to Follow investment picks
CHARLOTTE, N.C., Oct.
Sign-up for Agnesian HealthCare Joins Premier, Inc. to Provide More Efficient, Cost-Effective Care investment picks
FARMINGTON HILLS, Mich.
Sign-up for Agree Realty Corporation Reports Operating Results For The Third Quarter 2014 investment picks
2014/10/27
--Top-line Results Confirming Safety, Liver Transfection Presented at ESGCT Conference--
Sign-up for AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data from Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate investment picks
LEHIGH VALLEY, Pa.
Sign-up for Air Products to Work with Technip on Inner Mongolia LNG Project investment picks
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced positive top-line results from its Phase 2b placebo-controlled trial of AKB-6548 in non-dialysis patients with anemia related to chronic kidney disease (CKD). The study achieved its primary endpoint and AKB-6548 was generally well tolerated, confirming that the once-daily, oral therapy can successfully increase and maintain hemoglobin (HGB) levels.
Sign-up for Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease investment picks
2014/10/27
Alacer Gold Reports 27% Increase in Gold Production at Lower Costs for Third Quarter 2014 Canada NewsWire TORONTO , Oct.
Sign-up for Alacer Gold Reports 27% Increase in Gold Production at Lower Costs for Third Quarter 2014 investment picks
Alibaba (BABA) was started with a buy rating and a $118 price target at Jefferies on Monday, with the brokerage predicting that more than half of China will be using its platforms to make online purchases within the decade.
Sign-up for Alibaba to double Chinese users within the decade investment picks
Allergan Inc. (AGN) said Monday it would consider an improved bid from Valeant Pharmaceuticals International Inc. (VRX) , although it repeated that Valeant's offers have so far been inadequate and have undervalued Allergan.
Sign-up for Allergan board skeptical of Valeant's offer to improve bid investment picks
Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued the following statement in response to Valeant Pharmaceuticals International, Inc.’s (“Valeant”) October 27, 2014 letter to the Allergan Board of Directors.
Sign-up for Allergan Comments on Valeant Letter investment picks
Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended September 30, 2014.
Sign-up for Allergan Reports Third Quarter 2014 Operating Results investment picks
2014/10/27
NEW YORK , Oct.
Sign-up for Alliance California Municipal Income Fund Releases Monthly Portfolio Update investment picks
Alliance Holdings GP, L.P. (NASDAQ: AHGP) today reported quarterly financial results for the quarter ended September 30, 2014 (the "2014 Quarter"). On the strength of solid results by its operating subsidiary, Alliance Resource Partners, L.P. (NASDAQ: ARLP), AHGP’s net income rose 26.4% to $68.5 million, or net income per basic and diluted limited partner interest of $1.15 per unit, an increase of 26.4% compared to the quarter ended September 30, 2013 (the "2013 Quarter"). (Operating results for AHGP reflect those of the operating subsidiaries of ARLP and, as a result, AHGP reports its financial results on a consolidated basis with the financial results of ARLP.
Sign-up for Alliance Holdings GP, L.P. Increases Quarterly Distribution by 2.6% to $0.8925 Per Unit; Quarterly Net Income Increases 26.4% investment picks
NEW YORK , Oct.
Sign-up for Alliance New York Municipal Income Fund RELEASES MONTHLY PORTFOLIO UPDATE investment picks
Alliance Resource Partners, L.P. (NASDAQ: ARLP) today reported increased financial and operating results for the quarter ended September 30, 2014 (the "2014 Quarter"). Led by higher coal sales volumes, revenues climbed to $569.3 million, an increase of 6.0% compared to the quarter ended September 30, 2013 (the "2013 Quarter"). Increased revenues and coal sales volumes contributed to higher EBITDA, which increased 24.8% to $197.8 million, and net income, which jumped 37.6% to $120.0 million, or $1.13 of net income per basic and diluted limited partner unit.
Sign-up for Alliance Resource Partners, L.P. Reports Net Income up 37.6% and EBITDA up 24.8% due to Increased Coal Sales, Revenues and Production Volumes; Raises Quarterly Cash Distribution 2.0% to $0.6375 Per Unit investment picks
2014/10/27
NEW YORK , Oct.
Sign-up for AllianceBernstein Closed-End Funds Announce Distribution Rates investment picks
NEW YORK , Oct.
Sign-up for AllianceBernstein Income Fund Releases Monthly Portfolio Update investment picks
- Net Sales $553 million, Adjusted Net Income $138 million, Adjusted EBITDA $202 million, Adjusted Free Cash Flow $159 million or $0.88 per Diluted Share INDIANAPOLIS , Oct.
Sign-up for Allison Transmission Announces Third Quarter 2014 Results investment picks
Fiserv , Inc. (NASDAQ: FISV), a leading global provider of financial services technology solutions, announced today that Altra Federal Credit Union, based in Onalaska, Wis., has selected the DNA ™ account processing platform and a host of complementary Fiserv solutions.
Sign-up for Altra Federal Credit Union Chooses DNA to Build Member Loyalty investment picks
NEW YORK, Oct.
Sign-up for Ambac to Release Third Quarter 2014 Earnings on November 10, 2014 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting to Ambac to Release Third Quarter 2014 Earnings on November 10, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent